News
Japan to remain Asia-Pacific's most attractive pharmaceuticals market
Despite a pricing regime that limits revenue-generation opportunities for companies.
Japan to remain Asia-Pacific's most attractive pharmaceuticals market
Despite a pricing regime that limits revenue-generation opportunities for companies.
Farrer Park Hospital CEO to tackle healthcare innovation in Singapore
How should "high touch" be intertwined with "high tech"?
Taiwan faces headwinds in upgrading long-term care
Training for caregivers is still inadequate.
China's drugmakers face headwinds despite regulatory improvements
Accessibility to innovative medicines is still an issue.
Singapore's health ministry to inject $24m funding to strengthen manpower
About 9,000 additional staff will be needed until 2020.
Why you shouldn't miss 2017 Healthcare Asia's Leadership Roundtable
Thought leaders from 7 hospitals will be converging in one roundtable.
Raffles Medical Group's full-year profit up 1.3% to $70.2m
Thanks to healthcare services' 30.8% revenue growth.
China M&A projected to track close to 2016's achievements
The previous year had new record highs.
Thailand eyes reforming its universal health coverage
UHC is primarily funded by taxation.
Healthcare Asia Forum 2017 commences its 3-city roadshow in Manila
It was attended by around 60 healthcare industry players from the Philippines.
Hong Kong's Gleneagles Hospital to charge extra 20% for common surgical procedures
This is applicable to patients with long-term illnesses.
China's medical device market predicted to grow 10.5% in under a decade
Total spend will hit CNY210.4b.
Here's what you should expect at the 2017 Healthcare Asia Forum
It will be on February 16 at the Makati Shangri-La.
Cardinal Santos Medical Center's CIO to speak at the 2017 Healthcare Asia Forum
Find out what his discussion points are.
China's healthcare industry lures private equity investors
Rising income and a silver population boost demand for medical services.
Why Indonesia's ambition of universal healthcare by 2019 will be "highly difficult"
Health insurance scheme's impact is likely to wane, analysts say.
Medicine spending in Hong Kong to grow from $9.6b in 2016 to $13.4b by 2021
That is a CAGR of 6.5%.